Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles: 2020-2025
Historic Amortizatization of Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Sep 2025 value amounting to $2.6 million.
- Aurinia Pharmaceuticals' Amortizatization of Intangibles fell 23.27% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 17.11%. This contributed to the annual value of $12.7 million for FY2024, which is 4.86% up from last year.
- Per Aurinia Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $2.6 million for Q3 2025, which was up 2.42% from $2.6 million recorded in Q2 2025.
- Over the past 5 years, Aurinia Pharmaceuticals' Amortizatization of Intangibles peaked at $3.4 million during Q3 2024, and registered a low of -$2.3 million during Q4 2021.
- In the last 3 years, Aurinia Pharmaceuticals' Amortizatization of Intangibles had a median value of $3.0 million in 2023 and averaged $3.0 million.
- In the last 5 years, Aurinia Pharmaceuticals' Amortizatization of Intangibles plummeted by 667.84% in 2021 and then spiked by 1,629.14% in 2023.
- Over the past 5 years, Aurinia Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at -$2.3 million in 2021, then surged by 168.94% to $1.6 million in 2022, then surged by 112.13% to $3.3 million in 2023, then decreased by 9.86% to $3.0 million in 2024, then decreased by 23.27% to $2.6 million in 2025.
- Its Amortizatization of Intangibles stands at $2.6 million for Q3 2025, versus $2.6 million for Q2 2025 and $2.7 million for Q1 2025.